Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03936309 · ClinicalTrials.gov registry record · NA
A Comparison of Scar Infiltration, Scar Deactivation, and Standard of Care for the Treatment of Chronic, Post-Surgical Pain After Cesarean Section
A NA study of Scar and Cesarean Section; Dehiscence, sponsored by Jennifer Loomis.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT03936309: Completed NA study of Scar and Cesarean Section; Dehiscence, sponsored by Jennifer Loomis.
NCT03936309 is a NA study of Scar and Cesarean Section; Dehiscence that has completed, run by Jennifer Loomis. The registered enrollment target is 60 participants, above the 45-participant average among 15 other Scar trials with a reported enrollment target (33% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03936309, a NA study of Scar and Cesarean Section; Dehiscence, has completed, sponsored by Jennifer Loomis.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
To compare scar infiltration with 0.5-1% Lidocaine at a dose of 3 mg/kg (max dose 300 mg) or scar deactivation with acupuncture surface release technique to determine which is more effective in reducing pain in adult patients with chronic, post-surgical pain related to the site of incision after low transverse Cesarean section compared to standard of care physical therapy with the McKenzie Method.
Primary Outcome
The DVPRS consists of an 11-point numerical rating scale with 0 indicating no pain and 10 indicating severe pain. It has been confirmed for reliability and validity in measuring both acute and chronic pain, and is currently the standard for pain measurement throughout DoD and VHA health systems. The DVPRS has demonstrated linear scale qualities allowing parametric methods to be used. The goal for pain reductions will be 50% as a primary outcome.
Conditions Studied
Interventions
- OTHER Physical therapy
- OTHER Scar Deactivation Surface Release Technique protocol
- OTHER Scar Infiltration with 0.25-1% Lidocaine
Study Locations (1)
Illinois
- 375th Medical Group - Scott Air Force Base
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2019-06-01 |
| Est. Completion | 2025-04-08 |
| Phase | NA |
What the finished NCT03936309 record still lists
NCT03936309 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, above the 45-participant average among 15 other Scar trials with a reported enrollment target (33% higher).
The record links to 2 conditions, with Scar appearing as the primary indexed condition, and to 3 interventions - of which Physical therapy is the first listed.
NCT03936309 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT03936309 about?
NCT03936309 is a clinical study titled "A Comparison of Scar Infiltration, Scar Deactivation, and Standard of Care for the Treatment of Chronic, Post-Surgical Pain After Cesarean Section". To compare scar infiltration with 0.5-1% Lidocaine at a dose of 3 mg/kg (max dose 300 mg) or scar deactivation with acupuncture surface release technique to determine which is more effective in reducing pain in adult patients with chronic, post-surgical pain related to the site of incision after low...
What is the current status of trial NCT03936309?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2019-06-01. Estimated completion is 2025-04-08.
What conditions does trial NCT03936309 study?
This clinical trial studies the following conditions: Scar, Cesarean Section; Dehiscence.
What interventions are being tested in trial NCT03936309?
The interventions under investigation include: Physical therapy (OTHER), Scar Deactivation Surface Release Technique protocol (OTHER), Scar Infiltration with 0.25-1% Lidocaine (OTHER).
Who is sponsoring clinical trial NCT03936309?
This trial is sponsored by Jennifer Loomis, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03936309 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Scar
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03936309's enrollment target sits among peer trials
60 4th of 15 higher than 12 of 15 other Scar trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Scar trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Microneedling vs Dermabrasion for Early Facial Scar Resurfacing
RECRUITING · NA
-
Paraffin Wax and Exercise Prospective
RECRUITING · NA
-
Impact of Suture Type on Pigment Disturbances in Patients of Skin of Color
RECRUITING · NA
-
CO2 Laser Revision for Burn Related Donor Site Scars
ACTIVE NOT RECRUITING · NA
-
Influence of Sun Protection and Linear Repair of Cutaneous Surgical Defects
ACTIVE NOT RECRUITING · NA
-
PDL and Fractional Photothermolysis for Postsurgical Scars
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI